WEDNESDAY, NOVEMBER 22, 2017

Women reminded to avoid cervical cancer by having Pap tests

The Michigan Department of Community Health (MDCH) recently reminded women that regular Pap tests can help prevent cervical cancer deaths. Read More »

NIAID seeks therapies for rare viral diseases

The Division of Microbiology and Infectious Diseases of the National Institute of Allergy and Infectious Diseases (NIAID) is seeking developers for therapies and strategies for emerging and rare viral diseases. Read More »

Incyte, Agenus team up to create better cancer treatments

Incyte and Agenus recently announced a global license, development and commercialization agreement that will focus on groundbreaking immuno-therapeutics using Agenus’ Retrocyte Display antibody discovery techniques. Read More »

WHO approves MenAfriVac meningitis vaccine for infants in Africa

The World Health Organization recently approved use of a new meningitis vaccine on infants after it was shown to be effective in sub-Saharan Africa. Read More »

Loyola University Health System: Flu vaccine sound despite mutation

The Loyola University Health System said on Wednesday that the current influenza vaccine set is valid despite an emerging strain reaching epidemic levels. Read More »

Researchers planning a single antivenom for sub-Saharan Africa

Scientists at the Liverpool School of Tropical Medicine (LSTM) plan to develop a new “universal antivenom” for sub-Saharan Africa, where some of the world’s most venomous snakes reside and endanger human health. Read More »

Rabies vaccine airdrop scheduled in Texas

The Texas Department of State Health Services recently announced that they will once again airdrop edible doses of the rabies vaccine throughout areas inhabited by Texas’ wildlife. Read More »

2 new Ebola vaccines could be tested in West Africa

The World Health Organization announced recently that two Ebola vaccines look to be safe and could soon be tested in West Africa. Read More »

Ovarian cancer oncolytic vaccine receives positive reviews

The European Medicines Agency's (EMA) Committee for Orphan Medical Products (COMP) recently gave a positive review of enadenotucirev to treat platinum-resistant ovarian cancer. Read More »

Western, Northeastern states see surge in flu activity

he Walgreens Flu Index, a weekly report that provides state- and market-specific information regarding flu activity, for the week beginning Jan. 12 was released Tuesday. Read More »

GeoVax making progress on Ebola vaccine program

GeoVax Labs, Inc., a biotechnology company that uses its unique vaccine delivery platform to create human vaccines, recently gave an update about the progress made in its Ebola vaccine development program. Read More »

Volunteers sought to test first oral HIV vaccine

A new oral vaccine to prevent HIV soon may be on the horizon. Read More »

Infection control improves in US hospitals

The Centers for Disease Control and Prevention (CDC) reported today that there have been improvements made in controlling infections that commonly spread through hospitals. Read More »

Combination treatment offers possible new solution for latent TB

JAMA Pediatrics recently reported that researchers had discovered that combining rifapentine and isoniazid to treat children with latent tuberculosis (TB) is equally as effective as longer treatment with just isoniazid. Read More »

New 'super mosquito' discovered in Mali

A new “super mosquito” has been discovered in Mali and researched by a team of researchers and scientists at the University of California-Davis. Read More »

Artists' collaboration spreads awareness on power of vaccines

The Bill & Melinda Gates Foundation recently introduced the Art of Saving a Life project, a collaboration of more than 30 world-renowned musicians, writers, filmmakers, painters, sculptors and photographers to show how vaccines have changed and continue to change the course of history. Read More »

Moncef Slaoui named to IAVI board

Dr. Moncef Slaoui, chairman of Global Vaccines at GlaxoSmithKline (GSK) has recently joined the Board of Directors of the International AIDS Vaccine Initiative (IAVI). Read More »

NIAID awards 3 contracts for drug studies

The National Institute of Allergy and Infectious Diseases (NIAID), a branch within the National Institutes of Health, recently raised the number of contracts that support early-stage human clinical trials of new investigational drugs. Read More »

LifeMap Sciences' VarElect phenotyper may have positive global results

LifeMap Sciences, Inc. announced recently the commercial release of VarElect, a powerful, user-friendly application for organizing gene variants resulting from next generation sequencing experiments. Read More »

NIH's malaria lab seeks contractors to conduct vaccine trials

New malaria vaccines are being created and developed and now need to be tested. Read More »